Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in IDXX — Idexx Laboratories Inc /De

CIK 1107261 HOUSTON, TX
Back to IDXX Full portfolio

Position in IDXX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$452,738
-$1,716,157 QoQ
Shares Held
860
-77.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#800
of 1,288 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $12,609,280 across 6 Diagnostics & Research names. IDXX ranks #5 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CSTL
Castle Biosciences Inc
 221,338 $5,278,911
2 ILMN
Illumina, Inc.
 26,700 $4,694,661
3 MEDP
Medpace Holdings, Inc.
 2,750 $1,456,372
4 BDSX
Biodesix Inc
 26,035 $587,089
5 IDXX
Idexx Laboratories Inc /De
This page 		860 $452,738
6 XGN
Exagen Inc.
 30,002 $139,509

All Filings in IDXX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $452,738 860
2026-03-31 $2,168,895 3,860
2025-12-31 $2,611,405 3,860
2024-03-31 $1,727,776 3,200
2023-12-31 $1,776,160 3,200
2022-12-31 $2,035,720 4,990
2022-09-30 $1,625,742 4,990
2022-06-30 $4,766,420 13,590
2022-03-31 $7,434,545 13,590
2021-12-31 $8,948,471 13,590
2021-09-30 $8,451,621 13,590
2021-06-30 $8,582,764 13,590
2021-03-31 $2,471,015 5,050
2020-12-31 $2,524,343 5,050